Physician profile
Jonathan E Mcghee
NPI 1912104829
$4,331.09
in general payments reported to CMS, 2019-2025
41 companies · $1,466 in 2025
The $1,466 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $43.53 · 2021: $470 · 2022: $535 · 2023: $389 · 2024: $956 · 2025: $1,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,810.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,076.47 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $378.30 | 2021-2025 | Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $240.33 | 2019-2024 | Xarelto, Spravato |
| Amgen INC. | $237.51 | 2019-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $225.56 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Corium, LLC | $202.65 | 2024-2025 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $176.67 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $150.88 | 2021 | |
| Novo Nordisk INC | $139.14 | 2024-2025 | Ozempic, Wegovy |
| Janssen Scientific Affairs, LLC | $136.38 | 2022 | |
| Pfizer INC. | $135.68 | 2019-2025 | |
| Zyla Life Sciences, INC. | $130.07 | 2019 | |
| Antares Pharma, INC. | $106.05 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Abbott Laboratories | $102.49 | 2024-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $86.70 | 2023-2025 | Cologuard Collection Kit |
Show all 37 companies
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mcghee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.